Looking Into Quest Diagnostics's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Quest Diagnostics (NYSE:DGX) has seen a decrease in its short interest by 18.55%, with 1.97 million shares sold short, representing 2.02% of its float. This is lower than the peer group average of 9.44%, indicating a more bullish sentiment towards the stock.
October 21, 2024 | 1:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Quest Diagnostics has experienced a significant decrease in short interest, now at 2.02% of its float, which is below the peer average. This suggests a more bullish sentiment towards the stock.
The decrease in short interest by 18.55% suggests that investors are less bearish on Quest Diagnostics compared to its peers, where the average short interest is 9.44%. This could indicate a potential bullish sentiment, as fewer investors are betting against the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100